WeWork Value Shrinks Even Further Without An IPO
Article By:
Lipper Alpha Insight
Read
Wednesday, September 18, 2019 5:56 AM EDT
Adam Neumann is in a bind. The WeWork founder needs to raise at least $3 billion through an initial public offering to unlock another $6 billion of bank credit.
In this article: WE
FV Lessons Learned From The WeWork IPO
Video By:
Interactive Brokers
Watch
Tuesday, September 17, 2019 12:05 AM EDT
Steve Sosnick, Interactive Brokers’ chief strategist, discusses the turmoil around the WeWork IPO.
In this video: WE
Week In Review: Hansoh Signs $1.5 Billion Cross-Border Deal For AI-Drug Discovery With Atomwise
Article By:
ChinaBio® Today
Read
Saturday, September 14, 2019 4:53 PM EDT
China's Hansoh Pharma formed an AI-based small molecule drug discovery collaboration worth up to $1.5 billion with Atomwise of San Francisco.
WeWork Valuation Crashes From $47 Billion To As Low As $10 Billion
Article By:
Tyler Durden
Read
Friday, September 13, 2019 12:12 PM EDT
The We Company's underwriters must be having serious trouble securing orders for WeWork's planned IPO.
In this article: WE
CBS-Viacom: Creating Value In Media
Article By:
MoneyShow.com
Read
Wednesday, September 11, 2019 4:14 PM EDT
CBS and Viacom have announced they will be merging in a stock deal, setting up an attractive value play in media.
WeWork - Another Wacky IPO: Sign Of A Top Coming
Article By:
Harry Dent
Read
Monday, September 9, 2019 11:32 PM EDT
Simon Black recently put out an interesting expose about WeWork and its astronomically valued IPO and here's the dirty little truth about WeWork...
HH WeWork Dents The Case For Private Markets
Article By:
Lipper Alpha Insight
Read
Saturday, September 7, 2019 7:21 PM EDT
The shared-office space company led by Adam Neumann may go public at a valuation as low as $20 billion, less than half the $47 billion implied by its last private fundraising just eight months ago.
Week In Review: PAG Pays $540 Million For 58% Stake In Hisun BioRay, A China Biotech
Article By:
ChinaBio® Today
Read
Saturday, September 7, 2019 4:35 PM EDT
PAG, a Hong Kong PE firm, will pay $540 million to acquire a 58% stake in Hisun BioRay, a China biologics company developing autoimmune and oncology drugs.
WeWork Targets $20-$30 Billion IPO Valuation, Huge Discount To Latest Private Round
Article By:
Tyler Durden
Read
Thursday, September 5, 2019 9:58 AM EDT
Four billion dollars from Softbank last year boosted WeWork into $40 billion territory, and the funding round in January brought it to $47 billion.
In this article: WE
WeWork Governance Fixes Highlight The Unfixable
Article By:
Lipper Alpha Insight
Read
Thursday, September 5, 2019 4:47 AM EDT
WeWork isn’t entirely unconscious when it comes to its own governance.
In this article: WE
Upstart Dental Unicorn’s IPO Is A Risky Bite
Article By:
Lipper Alpha Insight
Read
Wednesday, September 4, 2019 9:19 AM EDT
SmileDirectClub is going public. But this upstart dental unicorn, which on Tuesday revealed it is targeting a nearly $8 billion valuation, is a risky bite.
In this article: SDC
